Almaject is focused on the development, acquisition, and commercialization of injectable generic pharmaceutical products. The current portfolio of injectables covers a broad range of therapeutic areas. Our commercial, business development, and R&D teams are creating new opportunities to expand our portfolio into complex molecules.
Almaject Inc. is a US subsidiary of Alvogen. The parent company Alvogen, is a global, privately owned pharmaceutical company focused on the development, manufacturing and commercialization of generic, brand, OTC and biosimilar products around the world. Alvogen has commercial operations in 35 countries and operates four manufacturing and development hubs in the U.S., Romania, Korea and Taiwan.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Pine Brook, New Jersey, Us
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- almaject.com
- HQ
- Pine Brook, New Jersey
Almaject Questions
Almaject's website is almaject.com
Almaject's LinkedIn profile is https://www.linkedin.com/company/almajectpr
Almaject has
2 employees.
View email and phone details for 2
employees at Almaject.
Almaject's industry is
Pharmaceutical Manufacturing
Almaject's top competitors are
Lotus Pharmaceutical Co., Ltd,
Almatica Pharma, Inc.,
Fuji Pharma Co. Ltd.,
Aztiq,
Alvogen,
American Regent, Inc.,
Maison Wessman,
Sagent Pharmaceuticals,
Adalvo,
Alvotech.
Almaject's categories are Pharmaceutical Manufacturing
Almaject's founding year is 2020
